Francisco Sánchez-Girón

Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.

X. Soberón, Beatriz E Villegas-Torres, Francisco Sánchez-Girón, 2015, Gene.

Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes.

Francisco Sánchez-Girón, Francisco Alvarez-Mora, 2008, Archives of pathology & laboratory medicine.

Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos.

J. Fernández-López, G. Jiménez-Sánchez, I. Silva-Zolezzi, 2011, Pharmacogenomics.

Pharmacogenetics and rational drug use around the world.

Wei Zhang, H. McLeod, Francisco Sánchez-Girón, 2011, Pharmacogenomics.

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study

Francisco Sánchez-Girón, N. Chavez-Tapia, N. Méndez-Sánchez, 2021, Annals of Hepatology.

In Mexican Mestizos the HCP5 rs2395029 SNP may be a genetic marker for screening abacavir hypersensitivity.

A. Carnevale, Francisco Sánchez-Girón, 2012, Pharmacogenomics.